Conjoint Professor
Jeannette Lechner-ScottProfile page
Clinical Conjoint Professor
School of Medicine and Public Health
- Clinical Conjoint ProfessorSchool of Medicine and Public Health
- 0249213540 (Work)
BIOGRAPHY
Career Profile: Jeannette Lechner-Scott is a clinician scientist, senior staff specialist at the John Hunter Hospital, Newcastle Australia and conjoint Professor at the University of Newcastle. After graduating at the University of Heidelberg in Germany with a PhD in Neurophysiology, they pursued their neurology specialist training in Freiburg Germany and Basel, Switzerland. She completed the FRACP in Australia in 2003 and established the Hunter New England Neuroimmunology clinic in 2005. Prof Lechner-Scott is head of the MS research team at Hunter Medical Research Institute since 2005 achieving international recognition for their work in MS cognition, epigenetics and novel MRI techniques. She has extensive experience (over 25 years) in clinical trials, having been PI in over 30 national and international trials and currently leading two multicentre national clinical trial investigating biomarkers for longterm outcome of immune reconstitution (CLOBAS) and another trial investigating the effect of disease modifying treatment on artificial reproductive treatment in MS (ARTIMS).
J Lechner-Scott has been continuously funded over an extended period. Current combined grant funding from industry and public granting bodies exceeds $10 million. Current projects funded as CIA from the International Progression Alliance are epigenetics of progression in MS and CLOBAS and ARTIMS by a global pharmaceutical company. They lead as CI the epigenetic aspects of AusLong (GNT 1127819), a longitudinal study with significant impact as well as national trials measuring the impact of mitochondrial supplements (MRF1152317) and investigating the effect of EBV on MS (MRF2024369) as well as the first national treatment trial in MOG associated disease CureMOG (MRF 2030966).
Research Profile: J Lechner-Scott has co-authored 314 articles that include 248 peer-reviewed research reports, 21 reviews, 58 editorials and one book chapter. She has been cited 20,629 times (10,954 in the last 5 years). 23% of her publications are in the top 10% journals according to SJR. Her collaboration extends over 320 institutions from 90 countries including US and UK.
JLechner-Scott has been on the steering as well as safety committee of international pharmaceutical trials. Her leadership is evidenced by being the current chair of the MSRA clinical trials network and the past chair of the MS Australia platform ANZGene. J Lechner-Scott is part of the IMSGC (International MS Genetic Consortium) and leads the epigenetic subgroup of this program. In 2023 she has been awarded the IanMcDonald prize for excellence in MS research in Hobart.
J Lechner-Scott has mentored numerous medical students and junior doctors in their research projects but also in their clinical career but has also established a mentor program for women in neurology via ANZAN and is involved in the international program for Women in MS Research.
Research Impact: J Lechner-Scott is committed to improving the life of pwMS. While working in Basel Switzerland they developed a training module for assessing MS related disability via EDSS. This has become the required module for any international clinical trial in MS. Her work on the impact of MS on cognition has resulted in the acceptance of monitoring this aspect of disease in the clinical setting. The importance of this has been shown in her recent publication where she assessed the value of the government support package (NDIS) and its association with disability as measured by clinicians. This has been presented to the friends of parliament and will hopefully translate into policy change with regards to assessment for NDIS. 4 previous publications have influenced policies so far. 50 of her articles informed 432 news stories.
Community Engagement: JLechner-Scott is on the board of directors for MS Plus and the Australian delegate for the international MS Federation. She is on the board of the Hunter Postgraduate Medical Education Institute and serves as chief editor for the MS and Related Disorder Journal. She is on national and international advisory boards for pharmaceutical companies and has been invited to chair sessions and present at ANZAN, the European and Panasian Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS/ PACTRIMS) and the Korean Annual Neurology meeting but they were also invited as platform speaker to the national obstetrics and gynaecology meeting to report on pregnancy in women in MS. Her podcast for newly diagnosed pwMS has been the most frequented podcast on the MS Australia website in 2021.
Research Expertise: Neuromyelitis optica; Multiple Sclerosis; MRI; Cognition; Neuroimmunology; Epigenetics
UNIVERSITY OF NEWCASTLE APPOINTMENTS
- Clinical Conjoint ProfessorUniversity of Newcastle, School of Medicine and Public Health, Australia18 Oct 2004 - present
ACADEMIC POSITIONS
- Conjoint Associate ProfessorFaculty of health and medicine, Australia1 Nov 2011 - present
NON-ACADEMIC POSITIONS
- Senior Staff SpecialistHunter New England Health, Internal Medicine, Australia1 Feb 2004 - present
DEGREES
- Bachelor of MedicineUniversity of Heidelberg30 Nov 1991
- PhD (Medicine)University of Heidelberg30 Jun 1993
LANGUAGES
- EnglishCan read, write, speak, understand and peer review
- GermanCan read, write, speak, understand and peer review
- ItalianCan read, write, speak, understand and peer review
- FrenchCan read, write, speak, understand and peer review
PROFILE TYPE
- Conjoint
SUSTAINABLE DEVELOPMENT GOALS
- 3 Good Health and Well Being
- 4 Quality Education
SUPERVISION AVAILABILITY
- Available - Senior Supervisor
DISCIPLINE
- Focus Area not applicable